中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
2024
2023
2022
2021
2020
2019
2018
2024
2023
2022
2021
2020
2019
2018
Notification Letter with Request Form to Non-Registered Holders of Shares - Notice of Publication of Interim Report 2018
2018-09-20
2018 Interim Report
2018-09-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2018
2018-09-06
2018 Interim Results
2018-08-31
Change of Principal Place of Business in Hong Kong
2018-08-31
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF OVER-ALLOTMENT OPTION
2018-08-24
NOTICE OF BOARD MEETING
2018-08-20
VOLUNTARY ANNOUNCEMENT
2018-08-02
ANNOUNCEMENT - INSIDE INFORMATION - NEW DRUG APPLICATION FOR ALL-ORAL HCV TREATMENT FILED WITH CHINA FOOD AND DRUG ADMINISTRATION
2018-07-31
BOARD DIVERSITY POLICY
2018-07-31
«
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
